AKT1 down-stream targets, such as GSK3β, are also altered in schizophrenia, including a decreased level of GSK-3β protein phosphorylation and GSK-3β mRNA in the prefrontal cortex [29,58]. The gene discussed is AKT1; the disease is schizophrenia.